comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 01:14:53 - browse：15123

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Vivek Ramaswamy made waves in the debate, much as in biotech

leisure time

WSS

Trans patients at the end of life deserve respect and dignity

How the drug

FDA advisory panel to debate high blood pressure devices

Republicans love RFK Jr. What's that tell us about health in 2024?

Roche's accidental data boosts hopes for anti

H5N1 bird flu outbreak: Second human case reported, in Michigan

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

ASCO eve: Let’s set the table for this year's meeting

ChatGPT in medicine: STAT answers readers' burning questions

People can get long Covid without testing positive for virus: Study

Continuity nursing helped my family in our darkest PICU moments

As a primary care physician, here's how I hope to partner with AI

Continuity nursing helped my family in our darkest PICU moments

Listen: More tumult at BIO & coercive care for sickle cell patients

Heart attack and stroke risk calculators need revising

Study finds gene variants tied to breast cancer risk in Black women

hotspot

California store owner shot dead in dispute over displaying Pride flag: Police

Biogen joins immunology wave with $1.15 billion acquisition of HI

Intellia plays down concerns on accidental germline transmission

Wegovy improves function in certain heart failure patients

Former Pear Therapeutics executives start new VC firm

National associations that represent hospice owe an apology

explore

knowledge

leisure time

focus